Suresh Ramalingam tells us what it’s like to become director of Emory Cancer Center and editor of Cancer—on the same day

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.

By coincidence, on that day he became the executive director of Winship Cancer Institute of Emory University and editor-in-chief of Cancer, a high-impact journal published by the American Cancer Society.

At Emory, Ramalingam, the center’s deputy director and the PI of the lung cancer SPORE succeeds Walter J. Curran Jr., who stepped down as executive director at Emory to become the global chief medical officer of GenesisCare (The Cancer Letter, Oct. 23, 2020).

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Editor & Publisher

YOU MAY BE INTERESTED IN

Editor & Publisher

Login